#pcsk9 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pcsk9, aggregated by home.social.
-
https://www.europesays.com/it/480223/ colesterolo LDL più basso riduce il rischio del 36% #Anmco2026 #AnticorpoMonoclonale #aterosclerosi #cardiologia #ColesteroloAlto #ColesteroloLdl #CongressoAnmco #CureCardiache #evolocumab #Health #ictus #infarto #IT #Italia #Italy #MalattieCardiovascolari #pcsk9 #PrevenzioneCuore #PrevenzioneInfarto #RicercaMedica #rimini #RischioCardiovascolare #RischioInfarto #Salute #SaluteCuore #StudioVesalius
-
How can LDL-cholesterol ("bad" cholesterol) be lowered in patients? Danila Branca gave an exciting talk at #Lunteren2026 on the development of orally bioavailable, macrocyclic peptide-based inhibitors of PCSK9 that were initially discovered by mRNA display and investigated by Merck in a clinical phase 3 study as enlicitide.
https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01084
https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01599 -
How can LDL-cholesterol ("bad" cholesterol) be lowered in patients? Danila Branca gave an exciting talk at #Lunteren2026 on the development of orally bioavailable, macrocyclic peptide-based inhibitors of PCSK9 that were initially discovered by mRNA display and investigated by Merck in a clinical phase 3 study as enlicitide.
https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01084
https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01599 -
How can LDL-cholesterol ("bad" cholesterol) be lowered in patients? Danila Branca gave an exciting talk at #Lunteren2026 on the development of orally bioavailable, macrocyclic peptide-based inhibitors of PCSK9 that were initially discovered by mRNA display and investigated by Merck in a clinical phase 3 study as enlicitide.
https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01084
https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01599 -
How can LDL-cholesterol ("bad" cholesterol) be lowered in patients? Danila Branca gave an exciting talk at #Lunteren2026 on the development of orally bioavailable, macrocyclic peptide-based inhibitors of PCSK9 that were initially discovered by mRNA display and investigated by Merck in a clinical phase 3 study as enlicitide.
https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01084
https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01599 -
Genetic insights into causal effects of lipids and lipid-modifying targets on calcific aortic valve stenosis: a Mendelian randomized study
Genetic variant…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #Calcificaorticvalvestenosis #Cardiovasculargenetics #Epidemiology #eQTL #Geneticsresearch #HumanitiesandSocialSciences #LDL-C #Lipidsprofile #Mendelianrandomization #multidisciplinary #PCSK9 #pQTL #Riskfactors #Science #Valvulardisease
https://www.newsbeep.com/us/76452/ -
Genetic insights into causal effects of lipids and lipid-modifying targets on calcific aortic valve stenosis: a Mendelian randomized study
Genetic variant…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #Calcificaorticvalvestenosis #Cardiovasculargenetics #Epidemiology #eQTL #Geneticsresearch #HumanitiesandSocialSciences #LDL-C #Lipidsprofile #Mendelianrandomization #multidisciplinary #PCSK9 #pQTL #Riskfactors #Science #Valvulardisease
https://www.newsbeep.com/us/76452/ -
A nice overview on #PCSK9 #inhibitors and related #medchem opportunities.
https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.2c01290